Milestone Scientific Inc. (MLSS)
USD 1.09
(0.93%)
USD 1.09
(0.93%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.35 Million USD | -9.11% |
| 2022 | 3.69 Million USD | 2.82% |
| 2021 | 3.59 Million USD | 3.75% |
| 2020 | 3.46 Million USD | -29.69% |
| 2019 | 4.92 Million USD | 1.13% |
| 2018 | 4.87 Million USD | -40.05% |
| 2017 | 8.12 Million USD | 62.1% |
| 2016 | 5.01 Million USD | 37.61% |
| 2015 | 3.64 Million USD | 49.64% |
| 2014 | 2.43 Million USD | -3.96% |
| 2013 | 2.53 Million USD | -31.92% |
| 2012 | 3.72 Million USD | -26.33% |
| 2011 | 5.05 Million USD | 18.21% |
| 2010 | 4.27 Million USD | 93.62% |
| 2009 | 2.2 Million USD | -26.63% |
| 2008 | 3.01 Million USD | -12.77% |
| 2007 | 3.45 Million USD | 141.65% |
| 2006 | 1.42 Million USD | 95.27% |
| 2005 | 731.39 Thousand USD | -13.81% |
| 2004 | 848.62 Thousand USD | -79.61% |
| 2003 | 4.16 Million USD | -43.36% |
| 2002 | 7.34 Million USD | 22.96% |
| 2001 | 5.97 Million USD | 40.38% |
| 2000 | 4.25 Million USD | 21.86% |
| 1999 | 3.49 Million USD | 288.06% |
| 1998 | 900 Thousand USD | -40.0% |
| 1997 | 1.5 Million USD | 114.29% |
| 1996 | 700 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.05 Million USD | 4.14% |
| 2024 Q1 | 3.89 Million USD | 15.82% |
| 2023 Q3 | 3.59 Million USD | 4.08% |
| 2023 Q1 | 3.02 Million USD | -18.24% |
| 2023 Q2 | 3.44 Million USD | 14.18% |
| 2023 FY | 3.35 Million USD | -9.11% |
| 2023 Q4 | 3.35 Million USD | -6.45% |
| 2022 Q4 | 3.69 Million USD | -9.81% |
| 2022 Q1 | 4.29 Million USD | 19.61% |
| 2022 Q3 | 4.09 Million USD | 6.8% |
| 2022 Q2 | 3.83 Million USD | -10.76% |
| 2022 FY | 3.69 Million USD | 2.82% |
| 2021 FY | 3.59 Million USD | 3.75% |
| 2021 Q1 | 3.6 Million USD | 4.03% |
| 2021 Q2 | 3.49 Million USD | -3.12% |
| 2021 Q3 | 4.04 Million USD | 15.98% |
| 2021 Q4 | 3.59 Million USD | -11.24% |
| 2020 Q4 | 3.46 Million USD | -15.52% |
| 2020 FY | 3.46 Million USD | -29.69% |
| 2020 Q1 | 5.88 Million USD | 19.46% |
| 2020 Q2 | 3.99 Million USD | -32.13% |
| 2020 Q3 | 4.1 Million USD | 2.65% |
| 2019 Q2 | 5.95 Million USD | 13.67% |
| 2019 FY | 4.92 Million USD | 1.13% |
| 2019 Q4 | 4.92 Million USD | -35.56% |
| 2019 Q3 | 7.64 Million USD | 28.51% |
| 2019 Q1 | 5.23 Million USD | 7.44% |
| 2018 Q2 | 8.1 Million USD | -3.46% |
| 2018 Q3 | 6.57 Million USD | -18.87% |
| 2018 Q4 | 4.87 Million USD | -25.94% |
| 2018 Q1 | 8.4 Million USD | 3.35% |
| 2018 FY | 4.87 Million USD | -40.05% |
| 2017 Q1 | 3.62 Million USD | -27.76% |
| 2017 FY | 8.12 Million USD | 62.1% |
| 2017 Q4 | 8.12 Million USD | 25.94% |
| 2017 Q3 | 6.45 Million USD | 18.73% |
| 2017 Q2 | 5.43 Million USD | 50.07% |
| 2016 Q4 | 5.01 Million USD | 14.05% |
| 2016 FY | 5.01 Million USD | 37.61% |
| 2016 Q1 | 3.24 Million USD | -11.04% |
| 2016 Q2 | 3.99 Million USD | 23.11% |
| 2016 Q3 | 4.39 Million USD | 10.17% |
| 2015 Q4 | 3.64 Million USD | 70.93% |
| 2015 Q3 | 2.13 Million USD | 9.91% |
| 2015 Q2 | 1.93 Million USD | 4.47% |
| 2015 Q1 | 1.85 Million USD | -23.75% |
| 2015 FY | 3.64 Million USD | 49.64% |
| 2014 Q3 | 2 Million USD | 2.73% |
| 2014 Q4 | 2.43 Million USD | 21.71% |
| 2014 Q1 | 2.2 Million USD | -12.9% |
| 2014 Q2 | 1.94 Million USD | -11.82% |
| 2014 FY | 2.43 Million USD | -3.96% |
| 2013 FY | 2.53 Million USD | -31.92% |
| 2013 Q1 | 3.41 Million USD | -8.38% |
| 2013 Q2 | 2.97 Million USD | -12.8% |
| 2013 Q4 | 2.53 Million USD | -0.71% |
| 2013 Q3 | 2.55 Million USD | -14.18% |
| 2012 FY | 3.72 Million USD | -26.33% |
| 2012 Q3 | 3.97 Million USD | -9.14% |
| 2012 Q2 | 4.36 Million USD | -5.46% |
| 2012 Q1 | 4.62 Million USD | -8.59% |
| 2012 Q4 | 3.72 Million USD | -6.19% |
| 2011 Q1 | 4.68 Million USD | 9.62% |
| 2011 FY | 5.05 Million USD | 18.21% |
| 2011 Q4 | 5.05 Million USD | 2.95% |
| 2011 Q3 | 4.91 Million USD | -6.85% |
| 2011 Q2 | 5.27 Million USD | 12.46% |
| 2010 FY | 4.27 Million USD | 93.62% |
| 2010 Q3 | 4.27 Million USD | 24.98% |
| 2010 Q2 | 3.42 Million USD | 14.7% |
| 2010 Q4 | 4.27 Million USD | -0.04% |
| 2010 Q1 | 2.98 Million USD | 35.12% |
| 2009 FY | 2.2 Million USD | -26.63% |
| 2009 Q1 | 3.1 Million USD | 3.09% |
| 2009 Q3 | 3.12 Million USD | -1.31% |
| 2009 Q4 | 2.2 Million USD | -29.42% |
| 2009 Q2 | 3.17 Million USD | 2.18% |
| 2008 Q4 | 3.01 Million USD | 13.26% |
| 2008 Q1 | 2.72 Million USD | -21.11% |
| 2008 FY | 3.01 Million USD | -12.77% |
| 2008 Q3 | 2.65 Million USD | -2.69% |
| 2008 Q2 | 2.73 Million USD | 0.32% |
| 2007 Q2 | 2.16 Million USD | 10.81% |
| 2007 FY | 3.45 Million USD | 141.65% |
| 2007 Q4 | 3.45 Million USD | 26.56% |
| 2007 Q1 | 1.95 Million USD | 36.93% |
| 2007 Q3 | 2.72 Million USD | 25.84% |
| 2006 Q1 | 1.05 Million USD | 44.33% |
| 2006 Q4 | 1.42 Million USD | 39.25% |
| 2006 Q3 | 1.02 Million USD | -22.17% |
| 2006 Q2 | 1.31 Million USD | 24.83% |
| 2006 FY | 1.42 Million USD | 95.27% |
| 2005 FY | 731.39 Thousand USD | -13.81% |
| 2005 Q4 | 731.39 Thousand USD | -31.61% |
| 2005 Q2 | 1.02 Million USD | -1.33% |
| 2005 Q1 | 1.03 Million USD | 22.07% |
| 2005 Q3 | 1.06 Million USD | 4.63% |
| 2004 Q1 | 878.7 Thousand USD | -78.88% |
| 2004 FY | 848.62 Thousand USD | -79.61% |
| 2004 Q4 | 848.62 Thousand USD | -12.23% |
| 2004 Q3 | 966.9 Thousand USD | -9.83% |
| 2004 Q2 | 1.07 Million USD | 22.04% |
| 2003 Q3 | 4.39 Million USD | -49.0% |
| 2003 FY | 4.16 Million USD | -43.36% |
| 2003 Q2 | 8.6 Million USD | 6.78% |
| 2003 Q1 | 8.06 Million USD | 9.75% |
| 2003 Q4 | 4.16 Million USD | -5.24% |
| 2002 Q4 | 7.34 Million USD | 5.51% |
| 2002 FY | 7.34 Million USD | 22.96% |
| 2002 Q1 | 5.9 Million USD | -1.13% |
| 2002 Q2 | 6.65 Million USD | 12.71% |
| 2002 Q3 | 6.96 Million USD | 4.58% |
| 2001 Q4 | 5.97 Million USD | 4.17% |
| 2001 FY | 5.97 Million USD | 40.38% |
| 2001 Q2 | 5.38 Million USD | 2.87% |
| 2001 Q3 | 5.73 Million USD | 6.43% |
| 2001 Q1 | 5.23 Million USD | 23.09% |
| 2000 Q4 | 4.25 Million USD | 12.51% |
| 2000 Q3 | 3.78 Million USD | 44.02% |
| 2000 Q2 | 2.62 Million USD | 20.18% |
| 2000 FY | 4.25 Million USD | 21.86% |
| 2000 Q1 | 2.18 Million USD | -37.42% |
| 1999 Q2 | 3 Million USD | 150.0% |
| 1999 Q1 | 1.2 Million USD | 33.33% |
| 1999 FY | 3.49 Million USD | 288.06% |
| 1999 Q3 | 3.2 Million USD | 6.67% |
| 1999 Q4 | 3.49 Million USD | 9.14% |
| 1998 Q2 | 3.5 Million USD | 34.62% |
| 1998 FY | 900 Thousand USD | -40.0% |
| 1998 Q4 | 900 Thousand USD | -50.0% |
| 1998 Q3 | 1.8 Million USD | -48.57% |
| 1998 Q1 | 2.6 Million USD | 73.33% |
| 1997 FY | 1.5 Million USD | 114.29% |
| 1997 Q4 | 1.5 Million USD | 50.0% |
| 1997 Q3 | 1 Million USD | -9.09% |
| 1997 Q2 | 1.1 Million USD | 57.14% |
| 1997 Q1 | 700 Thousand USD | 0.0% |
| 1996 FY | 700 Thousand USD | 0.0% |
| 1996 Q4 | 700 Thousand USD | 250.0% |
| 1996 Q2 | -100 Thousand USD | 0.0% |
| 1996 Q3 | 200 Thousand USD | 300.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| InfuSystem Holdings, Inc. | 57.58 Million USD | 94.167% |
| Retractable Technologies, Inc. | 80.38 Million USD | 95.821% |
| Stereotaxis, Inc. | 19.98 Million USD | 83.196% |